Advisors Asset Management Inc. lowered its stake in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 9.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 99,531 shares of the medical research company’s stock after selling 9,952 shares during the quarter. […]
Advisors Asset Management Inc. decreased its holdings in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 9.1% in the fourth quarter, Holdings Channel reports. The fund owned 99,531 shares of the medical research company’s stock after selling 9,952 shares during the period. Advisors Asset Management Inc.’s holdings in Amgen were worth $26,141,000 at the end of […]
Callan Capital LLC boosted its position in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 74.3% during the fourth quarter, HoldingsChannel reports. The fund owned 2,205 shares of the medical research company’s stock after buying an additional 940 shares during the quarter. Callan Capital LLC’s holdings in Amgen were worth $579,000 as of its most recent […]
Glovista Investments LLC decreased its holdings in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 0.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,062 shares of the medical research company’s stock after selling 47 shares during the quarter. Amgen makes up about 0.9% […]
Wealthcare Advisory Partners LLC lifted its position in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 9.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,852 shares of the medical research company’s stock after acquiring an additional 762 shares during the period. […]